MaxCyte Inc at Stephens Investment Conference (Virtual) Transcript
Good morning, everybody. Welcome to day one of the Stephens Investment Conference. I'm Jacob Johnson, life science tools and diagnostics analyst here at Stephens. Really delighted to be joined by the team from MaxCyte. We've got CEO, Doug Doerfler today with us; along with Sean Menarguez from Investor Relations.
(Conference Instructions) And with that out of the way, Doug, I'll turn it over to you for some opening comments, and then we'll launch into Q&A.
Well, thanks, Jacob. It is really a pleasure to be here, our first Stephens Conference and obviously virtual. And thank you for you and your team's support during this incredible process as a public company. So thanks, Jacob. Looking forward to today's discussion. Thank you.
Questions & Answers
Short and sweet. I like it, Doug. So maybe to kick things off, for those who may be less familiar with MaxCyte and the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
